Senior insider sale
Chief Medical Officer at VERA THERAPEUTICS, INC. — senior position signals high conviction
$7.26M
219.28K shares
What this filing means
LIN CELIA plans to sell 219.28K shares of VERA THERAPEUTICS, INC. valued at approximately $7.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/29/2024ACC: 0001950047-24-000497
Officer· Chief Medical Officer
Since May 2021
219.28K
Shares to sell
$7.26M
Approx. market value
219.28K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
1/29/2024
219.28KTotal acquired219.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/29/2024 | Exercise of options under a registered plan Cash | 219.28K | — |
| Total | 219.28K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
219.28K
Market value
$7.26M
1/29/2024
Total
Units
219.28K
Value
$7.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/29/2024 | 219.28K | $7.26M | NASDAQ | Planned |
| Total | 219.28K | $7.26M | ||